ECG247 participated this week at Medica in Düsseldorf, the world’s largest medical trade fair, marking three content-rich and inspiring days. The event provided an excellent opportunity to meet both existing and potential distributors from a wide range of countries, and we are pleased to see that interest in our technology continues to grow.

Growing Market Attention

It is gratifying to witness the significant attention ECG247 is receiving in the market. Many stakeholders see clear potential for our solution in new user groups and clinical settings. We engaged in several constructive discussions about pilot projects, integration into digital health solutions, and opportunities for broad implementation.

Clinical Documentation Builds Trust

A clear trend throughout the exhibition was that the solid research behind ECG247 is attracting attention. Studies such as NORSCREEN and comparisons with traditional Holter monitoring were frequently referenced in conversations with clinicians and distributors. The fact that our solution is documented as both user-friendly and diagnostically accurate strengthens our credibility and increases demand.

New Segments Show Interest

It also became evident that several players see potential for ECG247 in new user groups, including sports, military health, preventive health services, and telemedicine. This opens up exciting opportunities for further growth in the years ahead.